Filter News
Area of Research
- (-) Clean Energy (27)
- (-) Computational Biology (2)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (32)
- Computational Engineering (2)
- Computer Science (7)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (27)
- Fusion Energy (13)
- Isotope Development and Production (1)
- Isotopes (9)
- Materials (54)
- Materials for Computing (3)
- National Security (23)
- Neutron Science (30)
- Nuclear Science and Technology (16)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (67)
News Topics
- (-) Artificial Intelligence (9)
- (-) Big Data (5)
- (-) Biomedical (8)
- (-) Fusion (1)
- (-) Physics (1)
- (-) Security (6)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (78)
- Advanced Reactors (6)
- Bioenergy (26)
- Biology (13)
- Biotechnology (4)
- Buildings (36)
- Chemical Sciences (14)
- Clean Water (8)
- Climate Change (21)
- Composites (17)
- Computer Science (26)
- Coronavirus (13)
- Critical Materials (9)
- Cybersecurity (8)
- Decarbonization (33)
- Energy Storage (72)
- Environment (54)
- Exascale Computing (2)
- Fossil Energy (2)
- Frontier (2)
- Grid (40)
- High-Performance Computing (8)
- Hydropower (2)
- Isotopes (1)
- Machine Learning (7)
- Materials (35)
- Materials Science (26)
- Mathematics (2)
- Mercury (3)
- Microelectronics (1)
- Microscopy (8)
- Molten Salt (1)
- Nanotechnology (8)
- National Security (5)
- Net Zero (3)
- Neutron Science (12)
- Nuclear Energy (7)
- Partnerships (12)
- Polymers (11)
- Quantum Science (2)
- Renewable Energy (1)
- Simulation (4)
- Statistics (1)
- Summit (5)
- Sustainable Energy (69)
- Transformational Challenge Reactor (3)
- Transportation (65)
Media Contacts
Carl Dukes’ career as an adept communicator got off to a slow start: He was about 5 years old when he spoke for the first time. “I’ve been making up for lost time ever since,” joked Dukes, a technical professional at the Department of Energy’s Oak Ridge National Laboratory.
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
Three researchers at ORNL have been named ORNL Corporate Fellows in recognition of significant career accomplishments and continued leadership in their scientific fields.
Researchers at the Department of Energy’s Oak Ridge National Laboratory and their technologies have received seven 2022 R&D 100 Awards, plus special recognition for a battery-related green technology product.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
University of Pennsylvania researchers called on computational systems biology expertise at Oak Ridge National Laboratory to analyze large datasets of single-cell RNA sequencing from skin samples afflicted with atopic dermatitis.
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
A new tool that simulates the energy profile of every building in America will give homeowners, utilities and companies a quick way to determine energy use and cost-effective retrofits that can reduce energy and carbon emissions.
A research team at Oak Ridge National Laboratory have 3D printed a thermal protection shield, or TPS, for a capsule that will launch with the Cygnus cargo spacecraft as part of the supply mission to the International Space Station.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.